Statistical consideration for clinical biomarker research in bladder cancer (Q36124883)

12 August 2017

1 reference

title

Statistical consideration for clinical biomarker research in bladder cancer (English)

1 reference

12 August 2017

0 references

0 references

Nuria Malats

7

0 references

Andrew Vickers

object named as

Andrew Vickers

3

0 references

Yair Lotan

2

object named as

Yair Lotan

1 reference

12 August 2017

4

Pierre I Karakiewicz

1 reference

12 August 2017

1

Shahrokh F Shariat

1 reference

12 August 2017

Bernd J Schmitz-Dräger

5

1 reference

PMCID

3407571

12 August 2017

Peter J Goebell

6

1 reference

12 August 2017

1 July 2010

1 reference

12 August 2017

1 reference

12 August 2017

28

1 reference

12 August 2017

389-400

1 reference

12 August 2017

4

1 reference

Assessing the performance of prediction models: a framework for traditional and novel measures

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Critical review of prostate cancer predictive tools

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Clinical trial designs for predictive biomarker validation: one size does not fit all.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Screening for bladder cancer using urine-based tumor markers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

An updated catalog of prostate cancer predictive tools

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Systematic review of statistical methods used in molecular marker studies in cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Guidelines for development of diagnostic markers in bladder cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Nomograms for bladder cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

New circulating biomarkers for prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Challenges of cancer biomarker profiling

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

The use and abuse of data: nomograms and talking to patients about clinical medicine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Method for evaluating prediction models that apply the results of randomized trials to individual patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Decision curve analysis: a novel method for evaluating prediction models

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Primer: using decision analysis to improve clinical decision making in urology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Biomarker discovery and validation: technologies and integrative approaches

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

The International Bladder Cancer Bank: proposal for a new study concept

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

New cancer biomarkers deriving from NCI early detection research.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Internal and external validation of predictive models: a simulation study of bias and precision in small samples

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Development of common data elements: the experience of and recommendations from the early detection research network

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Comparisons of nomograms and urologists' predictions in prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Traditional and newer pathologic factors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Cutpoints in clinical chemistry: time for fundamental reassessment

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Comparison of Cox Regression With Other Methods for Determining Prediction Models and Nomograms

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Nomograms provide improved accuracy for predicting survival after radical cystectomy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Precystectomy nomogram for prediction of advanced bladder cancer stage.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Game relativity: how context influences strategic decision making.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Reporting recommendations for tumor marker prognostic studies (REMARK).

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Heuristics and biases: selected errors in clinical reasoning.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Neural networks, logistic regression, and calibration

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407571

Search for biomarkers of aggressiveness in bladder cancer

23 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Bladder cancer markers in patient management: the current perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Detection of bladder cancer using a point-of-care proteomic assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Are biomarkers for bladder cancer beneficial?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Running before we can walk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Proteomic patterns to identify ovarian cancer: 3 years on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Perspectives on prostate cancer biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Role of biomarkers to predict outcomes and response to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Heuristic and linear models of judgment: matching rules and environments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

A catalog of prostate cancer nomograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.02.011

Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20610277

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nomograms. Introduction

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20610277

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2010.02.011

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

3407571